PepGen (PEPG) Other financing activities (2023 - 2026)

PepGen (PEPG) reported Other financing activities of $7000.0 for Q1 2026, up 100.01% sequentially from -$107.8 million in Q4 2025.

PepGen (PEPG) Other financing activities (2023 - 2026) Analysis & Trends

PepGen (PEPG) has 4 years of Other financing activities data on file, last reported at $7000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $299000.0 (changed N/A YoY), and the FY2025 full-year result was $292000.0, down 99.62% from the prior year.
  • Other financing activities climbed to $7000.0 in Q1 2026, from -$107.8 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $108.1 million in Q3 2025 to a low of -$107.8 million in Q4 2025.
  • A 4-year average of $11.1 million and a median of $85000.0 in 2023 frame the typical range for Other financing activities.
  • Peak annual rise in Other financing activities reached 59036.92% in 2024, while the deepest fall reached 59036.92% in 2024.
  • Tracing PEPG's Other financing activities over 4 years: stood at $38000.0 in 2023, then surged by 202210.53% to $76.9 million in 2024, then sank by 240.23% to -$107.8 million in 2025, then soared by 100.01% to $7000.0 in 2026.
  • Business Quant data shows PEPG's Other financing activities at $7000.0 in Q1 2026, -$107.8 million in Q4 2025, and $108.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 PepGen 145.09 Mn 145.09 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 7,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 -107.81 Mn
Dec 31, 2025 -107.81 Mn
Sep 30, 2025 108.10 Mn
Sep 30, 2025 108.10 Mn
Mar 31, 2024 76.88 Mn
Mar 31, 2024 76.88 Mn
Dec 31, 2023 38,000.00
Dec 31, 2023 38,000.00
Jun 30, 2023 85,000.00
Jun 30, 2023 85,000.00
Mar 31, 2023 130,000.00
Mar 31, 2023 130,000.00